Physician profile
Jared Beller
NPI 1225423510
$4,750.42
in general payments reported to CMS, 2019-2025
9 companies · $749 in 2025
The $749 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.93 · 2020: $85.19 · 2022: $666 · 2023: $420 · 2024: $2,804 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,333 · Travel and Lodging: $1,639.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,333.44 |
| Travel and Lodging | $1,639.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $2,994.32 | 2023-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System |
| Medtronic, INC. | $598.69 | 2022-2024 | Corevalve Evolut R |
| Ethicon US, LLC | $469.83 | 2024-2025 | Evarrest, Vistaseal, Prolene |
| Hemosonics LLC | $216.52 | 2022 | |
| Abbott Laboratories | $166.24 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Navitor |
| Abiomed | $130.42 | 2024 | Impella |
| Boston Scientific Corporation | $89.21 | 2025 | Avvigo Guidance System |
| Edwards Lifesciences Corporation | $85.19 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Beller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.